Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its target price reduced by Citigroup from $266.00 to $233.00 in a research note released on Tuesday morning, MarketBeat.com reports. They currently have a buy rating on the biopharmaceutical company’s stock. Several other research firms have also issued reports on ALNY. Royal Bank of Canada restated an outperform […]
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its target price cut by Evercore ISI from $252.00 to $210.00 in a research note issued to investors on Tuesday morning, FlyOnTheWall reports. Other equities research analysts also recently issued research reports about the stock. Citigroup decreased their target price on shares of Alnylam Pharmaceuticals from $266.00 to […]
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price target trimmed by BMO Capital Markets from $250.00 to $234.00 in a research note released on Tuesday morning, MarketBeat reports. The firm currently has an outperform rating on the biopharmaceutical company’s stock. A number of other analysts also recently weighed in on ALNY. Royal Bank of […]
Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Cut to $210.00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Evercore ISI Lowers Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $210.00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.